1. |
Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol, 1997, 50(6): 683-691.
|
2. |
刘凤琪, 石舒原, 杨智荣, 等. 网络Meta分析研究进展系列(七): 多水平网状Meta回归. 中国循证心血管医学杂志, 2020, 12(12): 1409-1412.
|
3. |
Cucherat M, Laporte S, Delaitre O, et al. From single-arm studies to externally controlled studies. Methodological considerations and guidelines. Therapie, 2020, 75(1): 21-27.
|
4. |
Aouni J, Gaudel-Dedieu N, Sebastien B. Matching-adjusted indirect comparisons: application to time-to-event data. Stat Med, 2021, 40(3): 566-577.
|
5. |
Phillippo DM, Dias S, Elsada A, et al. Population adjustment methods for indirect comparisons: a review of National Institute for Health and Care Excellence Technology Appraisals. Int J Technol Assess Health Care, 2019, 35(3): 221-228.
|
6. |
Phillippo DM, Ades AE, Dias S, et al. TSD 18: methods for population-adjusted indirect comparisons in submissions to NICE. 2023.
|
7. |
Phillippo DM, Ades AE, Dias S, et al. Methods for population-adjusted indirect comparisons in health technology appraisal. Med Decis Making, 2018, 38(2): 200-211.
|
8. |
Signorovitch JE, Wu EQ, Yu AP, et al. Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. Pharmacoeconomics, 2010, 28(10): 935-945.
|
9. |
Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med, 2016, 35(30): 5642-5655.
|
10. |
石丰豪, 商叶, 芮明军, 等. R语言survHE程序包在卫生经济学评价中的应用. 中国卫生经济, 2020, 39(9): 9-14.
|
11. |
Chen P, Wang X, Zhu S, et al. Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC. Front Public Health, 2022, 10: 956792.
|
12. |
Maloney DG, Kuruvilla J, Liu FF, et al. Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma. J Hematol Oncol, 2021, 14(1): 140.
|
13. |
Mt-Isa S, Abderhalden LA, Musey L, et al. Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20. Expert Rev Vaccines, 2022, 21(1): 115-123.
|
14. |
Thom H, Cheng V, Keeney E, et al. Matching-adjusted indirect comparison of crisaborole ointment 2% vs. topical calcineurin inhibitors in the treatment of patients with mild-to-moderate atopic dermatitis. Dermatol Ther (Heidelb), 2022, 12(1): 185-194.
|
15. |
刘颖欣, 王若婷, 黎国威. 匹配调整间接比较在医学研究中的应用. 中国循证医学杂志, 2022, 22(10): 1201-1205.
|
16. |
Ishak KJ, Proskorovsky I, Benedict A. Simulation and matching-based approaches for indirect comparison of treatments. Pharmacoeconomics, 2015, 33(6): 537-549.
|
17. |
Veroniki AA, Straus SE, Soobiah C, et al. A scoping review of indirect comparison methods and applications using individual patient data. BMC Med Res Methodol, 2016, 16: 47.
|
18. |
Gregory J, Smith S, Birnie R, et al. MAIC. 2023.
|